Dr. Reddy's Labs Files 6-K

Ticker: RDY · Form: 6-K · Filed: Nov 18, 2025 · CIK: 1135951

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

DRL filed a 6-K, standard reporting for foreign private issuer.

AI Summary

Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 18, 2025, reporting as a foreign private issuer. The company is based in Hyderabad, India, and its principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034. Dr. Reddy's Laboratories Ltd. is registered under the standard industrial classification for Pharmaceutical Preparations.

Why It Matters

This filing indicates ongoing reporting compliance for Dr. Reddy's Laboratories Ltd. as a foreign private issuer with the SEC.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial information or strategic changes.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to submit information that the company has made or is required to make public in its home country.

When was this Form 6-K filed?

This Form 6-K was filed on November 18, 2025.

What is the primary business of Dr. Reddy's Laboratories Ltd. according to the filing?

Dr. Reddy's Laboratories Ltd. is classified under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.

Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?

The filing indicates that Dr. Reddy's Laboratories Ltd. files annual reports under cover of Form 20-F.

Where is the principal executive office of Dr. Reddy's Laboratories Ltd. located?

The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-11-18 10:34:22

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: November 18, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing